Art

J-GLOBAL ID：200902240903339627   Reference number：07A0676003

Angiotensin II Receptor Blocker Losartan Improves Insulin Resistance

アンジオテンシンII受容体拮抗薬ロサルタンのインスリン抵抗性改善作用

Author (2)： UESHIBA HAJIME (東邦大 医 内科学糖尿病・代謝・内分泌科) ,  YOSHINO GEN (東邦大 医 内科学糖尿病・代謝・内分泌科)
Material： Therapeutic Research  (セラピューティック・リサーチ)
Volume： 28  Issue： 6  Page： 1169-1174  Publication year： Jun. 20, 2007 
JST Material Number： Y0681A  ISSN： 0289-8020  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *angiotensin antagonist ,...
Semi thesaurus term： insulin resistance ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0676003&from=J-GLOBAL&jstjournalNo=Y0681A") }}

JST classification (2)： Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Losartan

Reference (20)：

• Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.
• Morimoto S, Yano Y, Maki K, Sawada K. Renal and vascular protective effects of telmisartan in patients with essential hypertension. Hypertens Res 2006; 29: 567-72.
• Pfeffer MA, Swedberg K, Granger CB, et al. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-66.
• Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.
• Lithell H, Hansson L, Skoog I, et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-86.

Terms in the title (3)： アンジオテンシンII受容体拮抗薬 ,  ロサルタン ,  インスリン抵抗性改善作用